News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
513,988 Results
Type
Article (30315)
Company Profile (334)
Press Release (483332)
Multimedia
Podcasts (138)
Webinars (18)
Section
Business (136243)
Career Advice (440)
Deals (24813)
Drug Delivery (104)
Drug Development (67000)
Employer Resources (67)
FDA (12473)
Job Trends (10025)
News (239392)
Policy (19323)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1868)
Academic (1)
Accelerated approval (44)
ADA (44)
Adcomms (20)
Allergies (169)
Alliances (37137)
ALS (211)
Alzheimer's disease (1670)
Antibody-drug conjugate (ADC) (525)
Approvals (13041)
Artificial intelligence (643)
ASCO (293)
Autoimmune disease (343)
Automation (54)
Bankruptcy (179)
Best Places to Work (8468)
BIO (64)
BIOSECURE Act (15)
Biosimilars (214)
Biotechnology (239)
Bladder cancer (184)
Brain cancer (70)
Breast cancer (718)
Cancer (5790)
Cardiovascular disease (490)
Career advice (406)
Career pathing (21)
CAR-T (350)
CDC (15)
Celiac Disease (1)
Cell therapy (952)
Cervical cancer (46)
Clinical research (59624)
Collaboration (2181)
Commercialization (1)
Company closure (3)
Compensation (1122)
Complete response letters (76)
COVID-19 (2130)
CRISPR (116)
C-suite (1157)
Cystic fibrosis (145)
Data (7987)
Decentralized trials (1)
Denatured (49)
Depression (157)
Dermatology (86)
Diabetes (611)
Diagnostics (5395)
Digital health (55)
Diversity (9)
Diversity, equity & inclusion (19)
Drug discovery (354)
Drug pricing (101)
Drug shortages (19)
Duchenne muscular dystrophy (308)
Earnings (55241)
Editorial (46)
Employer branding (12)
Employer resources (61)
Events (89166)
Executive appointments (1051)
FDA (16064)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1693)
Gene editing (250)
Generative AI (56)
Gene therapy (741)
GLP-1 (960)
Government (2619)
Grass and pollen (8)
Guidances (343)
Healthcare (13079)
Hematology (194)
HIV (78)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (117)
Immunology and inflammation (286)
Immuno-oncology (98)
Indications (208)
Infectious disease (2434)
Inflammatory bowel disease (219)
Inflation Reduction Act (11)
Influenza (115)
Intellectual property (288)
Interviews (54)
IPO (12191)
IRA (24)
Job creations (1940)
Job search strategy (350)
JPM (55)
Kidney cancer (20)
Labor market (57)
Layoffs (398)
Leadership (22)
Legal (3258)
Liver cancer (88)
Longevity (31)
Lung cancer (764)
Lymphoma (449)
Machine learning (59)
Management (17)
Manufacturing (992)
Marketing (3)
MASH (204)
Medical affairs (1)
Medical device (9419)
Medtech (9525)
Mergers & acquisitions (13794)
Metabolic disorders (1481)
mRNA (216)
Multiple sclerosis (185)
NASH (18)
Neurodegenerative disease (437)
Neuropsychiatric disorders (98)
Neuroscience (3175)
Neurotech (1)
NextGen: Class of 2026 (3699)
Non-profit (2717)
Now hiring (57)
Obesity (655)
Opinion (209)
Ovarian cancer (222)
Pain (207)
Pancreatic cancer (325)
Parkinson's disease (374)
Partnered (30)
Patents (553)
Patient recruitment (708)
Peanut (62)
People (44809)
Pharmaceutical (59)
Pharmacy benefit managers (10)
Phase 1 (19021)
Phase 2 (26245)
Phase 3 (19737)
Pipeline (9012)
Policy (182)
Postmarket research (1833)
Preclinical (7898)
Press Release (60)
Prostate cancer (310)
Psychedelics (64)
Radiopharmaceuticals (335)
Rare diseases (1137)
Real estate (3724)
Recruiting (28)
Regulatory (18436)
Reports (30)
Research institute (1930)
Resumes & cover letters (49)
Rett syndrome (44)
RNA editing (31)
RSV (62)
Schizophrenia (173)
Series A (305)
Series B (213)
Service/supplier (4)
Sickle cell disease (126)
Special edition (23)
Spinal muscular atrophy (157)
Sponsored (43)
Startups (2743)
State (1)
Stomach cancer (12)
Supply chain (110)
Tariffs (39)
The Weekly (87)
Vaccines (894)
Venture capital (111)
Weight loss (402)
Women's health (114)
Worklife (5)
Date
Today (71)
Last 7 days (433)
Last 30 days (2057)
Last 365 days (26712)
2026 (14276)
2025 (26540)
2024 (30105)
2023 (33604)
2022 (43709)
2021 (46636)
2020 (42590)
2019 (32183)
2018 (24091)
2017 (24505)
2016 (22907)
2015 (26832)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (461)
Alabama (80)
Alaska (4)
Arizona (191)
Arkansas (13)
Asia (32962)
Australia (5704)
California (12006)
Canada (3278)
China (1523)
Colorado (492)
Connecticut (490)
Delaware (407)
Europe (74609)
Florida (1672)
Georgia (402)
Hawaii (4)
Idaho (37)
Illinois (906)
India (98)
Indiana (558)
Iowa (18)
Japan (596)
Kansas (114)
Kentucky (27)
Louisiana (40)
Maine (42)
Maryland (1367)
Massachusetts (9249)
Michigan (344)
Minnesota (555)
Mississippi (4)
Missouri (122)
Montana (32)
Nebraska (16)
Nevada (115)
New Hampshire (67)
New Jersey (3306)
New Mexico (28)
New York (3158)
North Carolina (1506)
North Dakota (10)
Northern California (6090)
Ohio (343)
Oklahoma (21)
Oregon (32)
Pennsylvania (2399)
Puerto Rico (29)
Rhode Island (38)
South America (651)
South Carolina (31)
Southern California (4755)
Tennessee (161)
Texas (1747)
United States (42227)
Utah (252)
Virginia (282)
Washington D.C. (65)
Washington State (990)
West Virginia (2)
Wisconsin (119)
Wyoming (2)
513,988 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer
Decnupaz is the first antibody-drug conjugate for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancer.
May 28, 2026
·
1 min read
·
Tristan Manalac
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.
May 18, 2026
·
1 min read
·
Tristan Manalac
Press Releases
NIH Awards Up to $4 Million to CraniUS Therapeutics to Advance Skull-Embedded Platform Designed to Bypass the Blood-Brain Barrier
June 29, 2026
·
4 min read
Cancer
Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy
Eli Lilly’s new JAK2 inhibitor—which it obtained from the recent acquisition of Ajax Therapeutics—reduced spleen volume by more than a third in 70% of patients with myelofibrosis.
June 15, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
·
1 min read
Press Releases
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
June 26, 2026
·
12 min read
Press Releases
Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply
March 30, 2026
·
4 min read
Layoffs
ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout
After 27 deaths were reported in a group receiving its blood cancer drug, ADC Therapeutics is downsizing, implementing layoffs for about 30 workers.
June 24, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference
June 2, 2026
·
1 min read
Press Releases
Riyadh Global Medical Biotechnology Summit Announces Scientific Program for 2026 Edition
International experts from leading universities, global biopharmaceutical companies, and investment organizations will convene in Riyadh, Saudi Arabia, September 14–16, 2026, for the fourth edition of RGMBS.
June 30, 2026
·
1 min read
1 of 51,399
Next
